Geode Capital Management
APGN

Geode Capital Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Geode Capital Management’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-178,760
Closed -$76.8K – 4839
2023
Q2 		$76.8K Hold
178,760
– – ﹤0.01% 4409
2023
Q1 		$89.4K Hold
178,760
– – ﹤0.01% 4383
2022
Q4 		$123K Sell
178,760
-380
-0.2% -$741 ﹤0.01% 4318
2022
Q3 		$483K Buy
+179,140
New +$1.46M ﹤0.01% 3749

Geode Capital Management's APGN Position: Q3 2023 in Review

Geode Capital Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 178,760 shares — an estimated $76.8K sold.

Geode Capital Management first reported a position in APGN in Q3 2022 and held it in 4 quarters. The position peaked at $483K in Q3 2022. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • Geode Capital Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Geode Capital Management sold 178,760 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $76.8K.
  • Geode Capital Management first reported a position in Apexigen, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Geode Capital Management's Apexigen, Inc. Common Stock position peaked at $483K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.